Literature DB >> 19772792

Association between polymorphisms in the FCGRT gene and lupus nephritis in Chinese patients.

X-J Zhou1, L Yu, L Zhu, P Hou, J-C Lv, F Yu, H Zhang.   

Abstract

OBJECTIVE: Studies on mouse models have indicated that the neonatal Fc receptor (FcRn) plays important roles in a variety of autoimmune diseases. A variable number of tandem repeat (VNTR) polymorphisms within the FCGRT gene have been detected, and were found to affect the expression and functioning of FcRn. This study investigated the possible association of FCGRT VNTR polymorphisms with susceptibility and clinical manifestations in patients with lupus nephritis (LN).
METHODS: A total of 404 Han Chinese subjects, comprising 200 patients with LN and 204 geographically-matched healthy controls, participated in the study. The FCGRT VNTR polymorphism was genotyped by DNA amplification using a touchdown polymerase chain reaction followed by polyacrylamide gel electrophoresis.
RESULTS: The distribution of VNTR polymorphisms within the FCGRT gene in Chinese subjects was different to that in Caucasians. Analysis of allele and genotype frequencies revealed no significant difference between LN patients and controls. There was no significant difference in the clinical features or prognosis in LN patients when stratified by VNTR polymorphism.
CONCLUSION: Our results suggest that VNTR polymorphisms within the FCGRT promoter are not associated with LN in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772792

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Clinical ramifications of the MHC family Fc receptor FcRn.

Authors:  Derry C Roopenian; Victor Z Sun
Journal:  J Clin Immunol       Date:  2010-09-17       Impact factor: 8.317

Review 2.  Neonatal Fc receptor: from immunity to therapeutics.

Authors:  Timothy T Kuo; Kristi Baker; Masaru Yoshida; Shuo-Wang Qiao; Victoria G Aveson; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

3.  Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.

Authors:  Willem-Jan R Fokkink; Annechien E G Haarman; Anne P Tio-Gillen; Wouter van Rijs; Ruth Huizinga; Pieter A van Doorn; Bart C Jacobs
Journal:  Ann Clin Transl Neurol       Date:  2016-05-17       Impact factor: 4.511

Review 4.  The value of repeat biopsy in lupus nephritis flares.

Authors:  Javier Narváez; Milagros Ricse; Montserrat Gomà; Francesca Mitjavila; Xavier Fulladosa; Olga Capdevila; Joan Torras; Xavier Juanola; Ramón Pujol-Farriols; Joan Miquel Nolla
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.